Exforge HCT 5 mg/160 mg/25 mg
As listed in the register: Exforge HCT 5 mg/160 mg/25 mg, Filmtabletten
5 mg + 160 mg + 25 mg ·
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Amlodipinum + Valsartanum + Hydrochlorothiazidum
- Made by
- Novartis Pharma Schweiz AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Essentielle Hypertonie
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Novartis Pharma Schweiz AG |
|---|---|
| Active substance | Amlodipinum + Valsartanum + Hydrochlorothiazidum |
| Used in | Heart, blood pressure and circulation |
| Strength | 5 mg + 160 mg + 25 mg |
| Classification | C09DX01 · Heart, blood pressure and circulation |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Exforge HCT 5 mg/160 mg/25 mg, Filmtabletten |
| Packs | 28 Tablette(n) · 98 Tablette(n) |
| Zulassungsnummer | 59407 |
| Dosisstärke | 3 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Amlodipinum + Valsartanum + Hydrochlorothiazidum